Sir Michael David Rawlins GBE FBPhS FMedSci (March 28, 1941 – January 20, 2023) was a British clinical pharmacologist who served as chair of the Medicines and Healthcare products Regulatory Agency from 2014 to 2020 and as chairman of UK Biobank until December 2019. From 1999 to 2013, he was chair of the National Institute for Health and Care Excellence (NICE), and from 2012 to 2014, he was president of the Royal Society of Medicine.
Rawlins was the Ruth and Lionel Jacobson Professor of Clinical Pharmacology at Newcastle University from 1973 to 2006. He joined the Committee on the Safety of Medicines in 1980, served as vice-chair from 1987 to 1992, and as head from 1993 to 1998. In 1998, he was appointed chairman of the Advisory Council on Drug Abuse, a position he held until 2008. He served as NICE’s Chair from its inception (as the National Institute for Clinical Excellence) in 1999 until April 2013.
He served on the Advisory Board of Incentives for Global Health, the non-profit organization that created the Health Impact Fund. Rawlins wrote a lot of articles, book chapters, and official publications. He delivered the Royal College of Physicians’ Bradshaw (1986), William Withering (1994), Samuel Gee (2006), and Harveian (2008) lectures.
Michael Rawlins Death: What Happened To Michael Rawlins?
Professor Sir Michael Rawlins, the Royal Society of Medicine’s President from 2012 to 2014, has died. “We are so sad to transmit the news of the demise of our much loved and esteemed colleague, Professor Sir Michael Rawlins,” stated Professor Roger Kirby, current President of the Royal Society of Medicine. He passed away in January 2023.
